Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

While Novo Nordisk's (NYSE: NVO) Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category doing well. While Elon Musk recently ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...

One billionaire investor whom investors of all sizes follow closely is Philippe Laffont of Coatue Management. Known for ...

Immunocore Holdings ( ) has provided an announcement. Immunocore Holdings has appointed Travis Coy as its new Executive Vice President, Chief Financial Officer, and Head of Corpor ...

By itself, it’s not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments ...

The weight loss industry has become one of the most profitable and popular sectors in healthcare. It will help Eli Lilly ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...

Detailed price information for Goldman Sachs Group (GS-N) from The Globe and Mail including charting and trades.

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...